Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III MelanomaSühendan Ekmekçioglu, Elizabeth A. Grimm, Roland L. Bassett et al.|Clinical Cancer Research|2016Cited by 51